Published in Br J Obstet Gynaecol on July 01, 1995
Antenatal maternal serum screening for Down's syndrome: results of a demonstration project. BMJ (1992) 9.08
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
Influence of tobacco marketing and exposure to smokers on adolescent susceptibility to smoking. J Natl Cancer Inst (1995) 4.61
A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int (2001) 3.42
Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies. Br Med J (1973) 2.41
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ (2009) 2.30
Does delaying pyeloplasty affect renal function in children with a prenatal diagnosis of pelvi-ureteric junction obstruction? BJU Int (2002) 2.25
Limited evolutionary conservation of imprinting in the human placenta. Proc Natl Acad Sci U S A (2006) 2.08
Placental lactogen levels as a screening test for fetal distress and neonatal asphyxia. Lancet (1972) 1.85
Microcomputers in antenatal care: a feasibility study on the booking interview. Br Med J (Clin Res Ed) (1981) 1.70
Levels of alpha-fetoprotein in maternal blood as a screening test for fetal neural-tube defect. Lancet (1975) 1.67
Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet (2006) 1.63
A rapid radioimmunoassay for human chorionic somatomammotrophin. J Obstet Gynaecol Br Commonw (1971) 1.54
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from urine and determination of the excretion rate for exogenous and endogenous oxytocin in human urine. J Endocrinol (1972) 1.43
Early amniocentesis: alphafetoprotein levels in amniotic fluid, extraembryonic coelomic fluid and maternal serum between 8 and 13 weeks. Br J Obstet Gynaecol (1991) 1.42
Lack of evidence for a circadian rhythm of IGFBP-1 in the mother and fetus during labour. Br J Obstet Gynaecol (1995) 1.41
Crown-rump length in aneuploid fetuses: implications for first-trimester biochemical screening for aneuploidies. Prenat Diagn (1995) 1.39
Simplified method for measuring sex-hormone binding globulin. Clin Chem (1981) 1.35
The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood. J Endocrinol (1970) 1.35
Specific and sensitive determination of pregnancy-specific beta 1-glycoprotein by radioimmunoassay. A new pregnancy test. Lancet (1977) 1.31
A rapid semi-automated method for the measurement of human chorionic somatomammotrophin. The normal range in the third trimester and its relation to fetal weight. J Obstet Gynaecol Br Commonw (1971) 1.30
The development of a radioimmunoassay and a plasma extraction method for vasopressin. J Endocrinol (1970) 1.28
Placental lactogen levels as guide to outcome of threatened abortion. Br Med J (1972) 1.24
Strengths and weaknesses of direct patient interviewing by a microcomputer system in specialist gynaecological practice. Eur J Obstet Gynecol Reprod Biol (1984) 1.20
The effects of beta-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer (1996) 1.19
Clinical and genetic findings in Hungarian patients with X-linked juvenile retinoschisis. Mol Vis (2008) 1.18
The development of on-line history-taking systems in antenatal care. Methods Inf Med (1983) 1.18
Concentrations of pregnancy-specific beta 1-glycoprotein in maternal blood in normal pregnancy and in intrauterine growth retardation. Lancet (1977) 1.17
Audit of compliance with antenatal protocols. BMJ (1992) 1.13
Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range. Br Med J (Clin Res Ed) (1984) 1.10
Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin? Clin Endocrinol (Oxf) (1988) 1.10
Dipstick method for human chorionic gonadotropin suitable for emergency use on whole blood and other fluids. Lancet (1985) 1.09
Frequency of implantation and early pregnancy loss in natural cycles. Baillieres Clin Obstet Gynaecol (1991) 1.09
alpha-Fetoprotein levels in pregnancies complicated by gastrointestinal abnormalities of the fetus. Br J Obstet Gynaecol (1977) 1.09
In vitro secretion of human chorionic gonadotrophin by bladder tumour cells. Br J Cancer (1987) 1.08
Ultrasound vs CT for the detection of ureteric stones in patients with renal colic. Br J Radiol (2001) 1.08
Release of oxytocin and vasopressin by the human foetus during labour. Nature (1971) 1.07
Oxytocin release by infused prostaglandin. Br Med J (1972) 1.06
Use of a rapid hCG-beta-subunit radioimmunoassay in acute gynaecological emergencies. Lancet (1980) 1.05
Evaluation and treatment of iatrogenic ureteral injuries during obstetric and gynecologic operations for nonmalignant conditions. J Am Coll Surg (1994) 1.05
Use of a microcomputer network for history taking in a prenatal clinic. Am J Perinatol (1985) 1.05
Circulating levels of pregnancy-specific beta1-glycoprotein in early pregnancy. Br J Obstet Gynaecol (1977) 1.03
Circulating levels of pregnancy specific beta 1 glycopretein in patients with testicular, bronchogenic and breast carcinomas. Cancer (1980) 1.03
The radioimmunoassay of placental protein 5 and circulating levels in maternal blood in the third trimester of normal pregnancy. Clin Chim Acta (1979) 1.02
A retrospective comparison of water births and conventional vaginal deliveries. Eur J Obstet Gynecol Reprod Biol (2000) 1.02
Human foetal pituitary peptides and parturition. Nature (1976) 1.02
Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. Am J Clin Pathol (2001) 1.01
Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer. Br J Urol (1989) 1.00
TER94, a Drosophila homolog of the membrane fusion protein CDC48/p97, is accumulated in nonproliferating cells: in the reproductive organs and in the brain of the imago. Insect Biochem Mol Biol (1998) 1.00
Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay. Lancet (1973) 1.00
Urinary multiple marker screening for Down's syndrome. Prenat Diagn (1995) 0.99
New bioassay for luteinizing hormone. Nature (1973) 0.99
The circulating levels of oxytocin following intravenous and intramuscular administration of Syntometrine. J Obstet Gynaecol Br Commonw (1972) 0.99
Familial inheritance of crossed fused renal ectopia. Pediatr Nephrol (2001) 0.98
Urinary beta-core human chorionic gonadotrophin: a new approach to Down's syndrome screening. Prenat Diagn (1994) 0.97
The fetus at risk. Lancet (1974) 0.97
Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older. Br J Obstet Gynaecol (1995) 0.97
Problems and pitfalls of risk assessment in antenatal care. Br J Obstet Gynaecol (1983) 0.97
Possible placental origin of ACTH in normal human pregnancy. Nature (1975) 0.96
Self-learning for a Bayesian knowledge base: how long does it take for the machine to educate itself? Methods Inf Med (1987) 0.96
The development of a radioimmunoassay for arginine-vasopressin: production of antisera and labelled hormone; separation techniques; specificity and sensitivity of the assay in aqueous solution. J Endocrinol (1972) 0.96
Placental protein 12 (PP12): a new test for the prediction of the small-for-gestational-age infant. Br J Obstet Gynaecol (1985) 0.95
Does prenatal diagnosis influence the morbidity associated with left in situ nonfunctioning or poorly functioning renal moiety after endoscopic puncture of ureterocele? J Urol (2005) 0.95
Serum fibrin(ogen) degradation products in diagnosis of deep-vein thrombosis and pulmonary embolism after hip surgery. Lancet (1975) 0.95
Simple renal cyst in a newborn. Br J Urol (1973) 0.95
Circulating levels of relaxin are normal in pregnant women with pelvic pain. Eur J Obstet Gynecol Reprod Biol (1997) 0.95
Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype. Br J Obstet Gynaecol (1993) 0.94
The development of radioimmunoassays for fibrinogen degradation products: fragments D and E. Br J Haematol (1975) 0.94
A relationship between sex hormone binding globulin and dehydroepiandrosterone sulfate in normally menstruating females. Gynecol Endocrinol (1987) 0.94
Doubts about human chorionic gonadotropin as a thyroid stimulator. Lancet (1985) 0.94
Observations on maternal oxytocin release during human labor and the effect of intravenous alcohol administration. Am J Obstet Gynecol (1976) 0.94
Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. Fetal Ther (1988) 0.93
Expression of beta human chorionic gonadotrophin by non-trophoblastic non-endocrine 'normal' and malignant epithelial cells. Br J Cancer (1990) 0.93
Immunological enhancement by mouse isoantibodies: the importance of complement fixation. Immunology (1968) 0.93
Circulating levels of prolactin during the menstrual cycle. Clin Endocrinol (Oxf) (1974) 0.93
Immunochemical analysis of the human chorionic gonadotrophin-like material secreted by 'normal' and neoplastic urothelial cells. J Mol Endocrinol (1989) 0.92
Raised alpha-fetoprotein in maternal serum with anencephalic pregnancy. Lancet (1973) 0.92
Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH). Br J Cancer (2000) 0.92
Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential. J Urol (1991) 0.92
Androgen suppression by hydrocortisone without aminoglutethimide in orchiectomised men with prostatic cancer. Br J Urol (1987) 0.92
The radioimmunoassay of oxytocin and vasopressin. J Endocrinol (1973) 0.92
Reproducibility of measurement of fetal biparietal diameter by ultrasonic cephalometry. J Obstet Gynaecol Br Commonw (1974) 0.91
Identification and purification of a new protein from water-soluble extracts of human adrenal gland. J Endocrinol (1979) 0.91
Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol (1996) 0.91
Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer. Br J Urol (1996) 0.91
A national survey to assess current use of computerised information systems in obstetrics. Br J Obstet Gynaecol (1993) 0.91
Placental lactogen levels in diabetic pregnancy. Br Med J (1973) 0.91
Development of a radioimmunoassay for adrenal specific protein: its measurement in biological fluids and tissues. J Endocrinol (1979) 0.91
Immunoreactive human chorionic gonadotrophin from the cyst fluid and CSF of patients with craniopharyngioma. Clin Endocrinol (Oxf) (1988) 0.91
Steroid hormone abnormalities in women with severe idiopathic constipation. Gut (1991) 0.90
Evaluation of an antenatal HIV testing programme in an inner London health district. Br J Obstet Gynaecol (1994) 0.90
The purification and development of a radioimmunoassay for beta-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women. J Endocrinol (1991) 0.90
Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab (1997) 0.90
Risk factors for HIV infection overlooked in routine antenatal care. J R Soc Med (1995) 0.90
Does the posterior sagittal approach with perirectal dissection impair fecal continence in a normal rectum? J Pediatr Surg (1996) 0.89
The routine use of ultrasound. Br J Obstet Gynaecol (1985) 0.89
Neonatal solitary renal cysts associated with posterior urethral valves. J Pediatr Surg (1979) 0.89
Relevance of anaesthesia for dofetilide-induced torsades de pointes in alpha1-adrenoceptor-stimulated rabbits. Br J Pharmacol (2007) 0.89
Circulating levels of fibrin/fibrinogen degradation fragment E measured by radioimmunoassay in pre-eclampsia. Br J Obstet Gynaecol (1976) 0.89